Tessier-Lavigne Marc's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Oct 3, 2022
- Accession no.
- 0001883850-22-000072
- Filed
- Oct 3, 2022
- Trade date
- Sep 29-Oct 3, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 17 non-derivative transactions and 3 derivative transactions. Open-market sales total $7.61M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tessier-Lavigne MarcCIK 0001437435 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2022 | Common Stock | MOption exerciseAcquired | +3,798 | $413.33 | +$1,569,827.34 | 6,067 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −16 | $686.89F2 | −$10,990.24 | 6,051 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −321 | $687.90F3 | −$220,815.9 | 5,730 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −637 | $688.71F4 | −$438,708.27 | 5,093 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −1,009 | $689.56F5 | −$695,766.04 | 4,084 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −692 | $690.65F6 | −$477,929.8 | 3,392 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −554 | $691.59F7 | −$383,140.86 | 2,838 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −85 | $696.13F8 | −$59,171.05 | 2,753 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −160 | $697.29F9 | −$111,566.4 | 2,593 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −208 | $698.44F10 | −$145,275.52 | 2,385 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −80 | $699.82 | −$55,985.6 | 2,305 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −16 | $702.36 | −$11,237.76 | 2,289 | Direct | |
| Sep 29, 2022 | Common Stock | SSaleDisposed | −20 | $704.83 | −$14,096.6 | 2,269 | Direct | |
| Sep 30, 2022 | Common Stock | MOption exerciseAcquired | +3,428 | $413.33 | +$1,416,895.24 | 5,697 | Direct | |
| Sep 30, 2022 | Common Stock | SSaleDisposed | −3,428 | $698.00 | −$2,392,744 | 2,269 | Direct | |
| Oct 3, 2022 | Common Stock | MOption exerciseAcquired | +3,612 | $413.33 | +$1,492,947.96 | 5,881 | Direct | |
| Oct 3, 2022 | Common Stock | SSaleDisposed | −3,612 | $718.00 | −$2,593,416 | 2,269 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2022 | Common Stock | MOption exerciseDisposed | −3,798 | $0.00 | $0 | 7,040 | Direct | |
| Sep 30, 2022 | Common Stock | MOption exerciseDisposed | −3,428 | $0.00 | $0 | 3,612 | Direct | |
| Oct 3, 2022 | Common Stock | MOption exerciseDisposed | −3,612 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 16 shares of Company stock on September 29, 2022 at prices ranging from $686.89 to $686.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 321 shares of Company stock on September 29, 2022 at prices ranging from $687.05 to $687.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 637 shares of Company stock on September 29, 2022 at prices ranging from $688.08 to $688.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 1,009 shares of Company stock on September 29, 2022 at prices ranging from $689.07 to $689.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 692 shares of Company stock on September 29, 2022 at prices ranging from $690.06 to $690.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 554 shares of Company stock on September 29, 2022 at prices ranging from $691.29 to $691.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 85 shares of Company stock on September 29, 2022 at prices ranging from $696.03 to $696.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 160 shares of Company stock on September 29, 2022 at prices ranging from $697.10 to $697.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 208 shares of Company stock on September 29, 2022 at prices ranging from $698.19 to $698.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.